Explore our company news, announcements and updates
September 29, 2026
MSD Animal Health Showcases New Research Advancing Ruminant Health at World Buiatrics Congress
August 24, 2026
Mexico’s SADER Approves MSD Animal Health’s BRAVECTO® (Fluralaner) Chew Tableta Masticable (Chew) for the Treatment of New World Screwworm (Cochliomyia hominivorax) in Dogs
July 31, 2026
European Commission Grants Marketing Authorization for NOBIVAC NXT HCPChFeLV from MSD Animal Health
July 20, 2026
Study from MSD Animal Health Reveals Opportunity to Increase Feline Vaccination through Knowledge Sharing Between Veterinarians and Cat Owners
June 17, 2026
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
June 4, 2026
New Research from MSD Animal Health Reveals “Hidden” Parasitic Infections Cost Global Dairy Industry Billions Each Year
February 25, 2026
FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from MSD Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis
February 24, 2026
MSD Animal Health Wins 2025 S&P Global Award in Best Product Companion Animal and Best Product Food Animal Categories for NUMELVI and INNOVAX® ND-IBD-ILT, Respectively
February 9, 2026
MSD Animal Health and FVE Reward 34 Veterinary Students from Across Europe
November 4, 2025
Mexico’s SADER Approves MSD Animal Health’s EXZOLT® 5% Pour-On (Fluralaner 50 mg/mL) for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (Myiasis)
October 23, 2025